首页> 外国专利> NOVEL CATIONIC POLYPHOSPHAZENE COMPOUNDS, POLYPHOSPHAZENE-DRUG CONJUGATE COMPOUNDS AND METHODS FOR PREPARING THE SAME

NOVEL CATIONIC POLYPHOSPHAZENE COMPOUNDS, POLYPHOSPHAZENE-DRUG CONJUGATE COMPOUNDS AND METHODS FOR PREPARING THE SAME

机译:新型阳离子型聚膦酸酯化合物,聚膦酸酯-药物共轭化合物及其制备方法

摘要

To provide new substances which have excellent cancer tissue selectivity and very low toxicity and are likely to be implemented as anticancer drugs.SOLUTION: The present invention can apply: cationic linear polyphosphazene compounds into which a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol are introduced; polyphosphazene-drug conjugate compounds obtained by chemically bonding hydrophobic drugs to the compounds; and preparation methods thereof.SELECTED DRAWING: Figure 12
机译:提供具有优异的癌组织选择性和极低毒性并且可能被用作抗癌药物的新物质。解决方案:本发明可以应用:阳离子线性聚磷腈化合物,其中选择了亲水性聚乙二醇和间隔基团从由赖氨酸组成的组中,引入包含赖氨酸的寡肽,氨基乙醇,氨基丙醇,氨基丁醇,氨基戊醇和氨基己醇;通过将疏水性药物化学键合到化合物上的聚磷腈-药物共轭化合物;及其制备方法。选图:图12

著录项

  • 公开/公告号JP2019123878A

    专利类型

  • 公开/公告日2019-07-25

    原文格式PDF

  • 申请/专利权人 CNPHARM CO LTD;SOHN YOUN SOO;

    申请/专利号JP20190045513

  • 申请日2019-03-13

  • 分类号C08G79/025;C08G81;A61K47/59;A61K47/65;A61K31/4745;A61K31/337;A61K31/282;A61P35;

  • 国家 JP

  • 入库时间 2022-08-21 12:24:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号